See All Slides - tctmd.com

Slides

Presentation TCT 2012

Bare Metal vs. Drug-Eluting Stents: Mechanisms of Action and Comparative Effectiveness and Safety

Presenter: Ajay Kirtane

October 23, 2012

Presentation TCT 2012

Follow the (Lack of) Evidence: Medical Therapy and CRT!

Presenter: Allan Schwartz

October 23, 2012

Presentation TCT 2012

Debate II. Is Straight-Line Flow to the Foot Sufficient (And Is the Angiosome Concept Nonsense)? Con!

Presenter: Andrej Schmidt

October 23, 2012

Presentation TCT 2012

Attributes of the Perfect LAA Closure Device: What All the Companies Should Strive For

Presenter: Horst Sievert

October 23, 2012

Presentation TCT 2012

Is Ischemia a Marker of Plaque Vulnerability and Future Thrombosis?

Presenter: Bernard De Bruyne

October 23, 2012

Presentation TCT 2012

TCT-7. Plaque Excision as a Treatment Option for Critical Limb Ischemia: 1-Year Results of the DEFINITIVE LE Study

Presenter: James McKinsey

October 23, 2012

Presentation TCT 2012

TCT-4. Impact of Catheter Fragmentation Followed by Local Intrapulmonary Thrombolysis in Acute High Risk Pulmonary Embolism as Primary Therapy: Acute and Long Term Outcomes

Presenter: Bishav Garg

October 23, 2012

Presentation TCT 2012

Case 1: During a TAVR

Presenter: Susheel Kodali

October 23, 2012

Presentation TCT 2012

TCT-81. Long-term Safety and Efficacy of Percutaneous Left Ventricular Transapical Access and Closure for Structural Heart Disease Interventions

Presenter: Chad Kliger

October 23, 2012

Presentation TCT 2012

TCT-371. First Clinical Evaluation of a Novel Percutaneous Right Ventricular Assist Device: The Impella RP

Presenter: Anson Cheung

October 23, 2012

Advertisement

Slides

Bare Metal vs. Drug-Eluting Stents: Mechanisms of Action and Comparative Effectiveness and Safety

Follow the (Lack of) Evidence: Medical Therapy and CRT!

Debate II. Is Straight-Line Flow to the Foot Sufficient (And Is the Angiosome Concept Nonsense)? Con!

Attributes of the Perfect LAA Closure Device: What All the Companies Should Strive For

Is Ischemia a Marker of Plaque Vulnerability and Future Thrombosis?

TCT-7. Plaque Excision as a Treatment Option for Critical Limb Ischemia: 1-Year Results of the DEFINITIVE LE Study

TCT-4. Impact of Catheter Fragmentation Followed by Local Intrapulmonary Thrombolysis in Acute High Risk Pulmonary Embolism as Primary Therapy: Acute and Long Term Outcomes

Case 1: During a TAVR

TCT-81. Long-term Safety and Efficacy of Percutaneous Left Ventricular Transapical Access and Closure for Structural Heart Disease Interventions

TCT-371. First Clinical Evaluation of a Novel Percutaneous Right Ventricular Assist Device: The Impella RP

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content